Vildagliptinum, Metformini hydrochloridum

Medicinal product name Daltex 50 mg/850 mg film-coated tablets
Pharmaceutical form Film-coated tablet
Strength 50 mg/850 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.)
Package leafletPDF 30-11-2023
Summary of product characteristicsPDF 30-11-2023
ATC code A10BD08 Drugs used in diabetes
Information for Marketing authorisation holdersView

Medicinal products (6)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N10
(50 mg/850 mg)
Al/Al blister    17-0207-01 Labelling text Labelling text May 31, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(50 mg/850 mg)
Al/Al blister    17-0207-02 Labelling text Labelling text May 31, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N60
(50 mg/850 mg)
Al/Al blister 22.85  17-0207-03 Labelling text Labelling text May 31, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N120
(50 mg/850 mg)
Al/Al blister    17-0207-04 Labelling text Labelling text May 31, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N180
(50 mg/850 mg)
Al/Al blister    17-0207-05 Labelling text Labelling text May 31, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N360
(50 mg/850 mg)
Al/Al blister    17-0207-06 Labelling text Labelling text May 31, 2018

Registration information

Marketing authorisation No. 17-0207
Date of authorisation Sep 11, 2017
Marketing authorisation holder, country Medochemie Ltd., Cyprus